Company intelligence / Profile preview

Nusmetics

Ownership: Private
Development stage: Commercial

Overview

Nusmetics develops advanced nano/microstructure-based drug delivery platforms designed to enhance the absorption and efficacy of active ingredients in cosmeceutical and pharmaceutical formulations. Their proprietary MINT platform claims up to 1000x higher drug delivery capability with minimalist formulations, targeting both healthcare and beauty sectors[1][3][5]. There are no published clinical results or late-stage programs as of June 2025.

Therapeutic areas: Dermatology
Modalities: Device (drug delivery device)Nanoparticle (nano/micro structures for drug delivery)
Industry: Therapeutic Medical Devices

Drug pipeline

4 assets

Microbee

Commercial

Indications: Drug delivery, Cosmetic

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Nusmetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nusmetics.

Explore the full profile